New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
17 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Global Targeted Sequencing Industry Research 2023-2033: Burgeoning Opportunities Adoption in Targeted Therapeutics in Oncology and Use in Clinical Research and Trials for Better Disease Pathogenesis
17 avr. 2024 04h33 HE
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture,...
Global Antisense and RNAi Therapeutics Report 2024: A USD 34.7 Billion Predicted Market by 2034, with CAGR of 18% During 2024-2034
16 avr. 2024 07h26 HE
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Antisense and RNAi Therapeutics Market" report has been added to ResearchAndMarkets.com's offering.The global antisense and RNAi therapeutics...
Global Precision Medicine Software Markets, 2023-2024 and 2033: Rise in Personalized Healthcare and Cloud-Based Delivery Mode-Based Platforms Elevating Data Accessibility
16 avr. 2024 05h51 HE
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Region - Analysis and Forecast,...
Global MicroRNA Market Exhibits Impressive Growth with a 12.20% CAGR through 2028
12 avr. 2024 10h12 HE
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "MicroRNA Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
10 avr. 2024 08h00 HE
|
Adrenomed AG
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths...
DNA Methylation Market Analysis 2024-2032 by Product, Technology, Application, End User, and Region - Industry to Rise at a 13.9% CAGR
09 avr. 2024 11h43 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "DNA Methylation Market Report by Product, Technology, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Global Orphan Drug Sector Poised for Growth Amidst Unmet Rare Disease Needs
05 avr. 2024 04h04 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study provides critical insights into the...
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04 avr. 2024 08h11 HE
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
01 avr. 2024 09h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...